317 related articles for article (PubMed ID: 34779630)
1. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
[TBL] [Abstract][Full Text] [Related]
2. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
Song H; Su C; Cui W; Zhu B; Liu L; Chen Z; Zhao L
Biomed Res Int; 2013; 2013():723158. PubMed ID: 24282819
[TBL] [Abstract][Full Text] [Related]
3. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
4. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
[TBL] [Abstract][Full Text] [Related]
5. Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment.
Sathiyaseelan A; Saravanakumar K; Manivasagan P; Jeong MS; Jang ES; Wang MH
Carbohydr Polym; 2022 Mar; 280():119021. PubMed ID: 35027124
[TBL] [Abstract][Full Text] [Related]
6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
7. Research of Gene Delivery Mediated by Ultrasound, Microbubble and Folate-modified Chitosan Nanoparticles.
Li Y; Lin Y; Liufu C; Tu J; Yang C; Chen Z
Curr Mol Med; 2018; 18(6):383-391. PubMed ID: 30411684
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX
Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible multi-walled carbon nanotube-chitosan-folic acid nanoparticle hybrids as GFP gene delivery materials.
Liu X; Zhang Y; Ma D; Tang H; Tan L; Xie Q; Yao S
Colloids Surf B Biointerfaces; 2013 Nov; 111():224-31. PubMed ID: 23831590
[TBL] [Abstract][Full Text] [Related]
10. Characterization, Cytotoxicity, and Genotoxicity of TiO
Tao R; Wang C; Zhang C; Li W; Zhou H; Chen H; Ye J
Biol Trace Elem Res; 2018 Jul; 184(1):60-74. PubMed ID: 28993980
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO
Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J
Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer.
Jamali S; Jamali B; Abedi F; Firoozrai M; Davaran S; Vaghefi Moghaddam S
J Biomater Sci Polym Ed; 2024 Apr; 35(5):605-627. PubMed ID: 38271010
[TBL] [Abstract][Full Text] [Related]
13. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Zhang S; Tang C; Yin C
Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.
Du YZ; Cai LL; Li J; Zhao MD; Chen FY; Yuan H; Hu FQ
Int J Nanomedicine; 2011; 6():1559-68. PubMed ID: 21845046
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
[TBL] [Abstract][Full Text] [Related]
17. Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth.
Nguyen VT; Doan P; Nguyen DT; Doan VD; Dao TP; Plavskii V; Nguyen BT; Tran NQ
J Biomater Sci Polym Ed; 2022 Mar; 33(4):426-442. PubMed ID: 34641768
[TBL] [Abstract][Full Text] [Related]
18. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of folic acid-conjugated chitosan-coated PLGA nanoparticles for targeted delivery of
Homayouni Tabrizi M
Nanotechnology; 2022 Sep; 33(49):. PubMed ID: 36121718
[TBL] [Abstract][Full Text] [Related]
20. Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation.
Sinai Kunde S; Wairkar S
Int J Pharm; 2022 Jul; 623():121926. PubMed ID: 35716974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
